Somalogic stock.

See the latest SomaLogic Inc Class A stock price (SLGC:XNAS), related news, valuation, dividends and more to help you make your investing decisions.SLGC | Complete SomaLogic Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.SomaLogic's stock surges as it agrees to be bought by Standard BioTools in all-stock merger. SomaLogic Inc.'s SLGC, -2.54% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with Stand...SomaLogic, Inc. (76X0.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock SomaLogic, Inc. | Börse Stuttgart: 76X0 | Börse Stuttgart

When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...

Public companies currently own 5.5% of SomaLogic stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged.

Aug 12, 2021 · The ownership percentages with respect to the post-combination and PIPE Investment are based on aggregate Merger Consideration of 125,000,000 shares of CMLS II Class A Common Stock (assuming no cash elections will be made by SomaLogic stockholders) and assume 116,013,417 shares will be issued at Closing to current holders of issued and ... Following the transaction, the combined company was renamed SomaLogic, Inc., and its Class A common stock and warrants will begin trading on the Nasdaq Global Market (“Nasdaq”) on September 2 ...6 oct 2023 ... Investors in Colorado-based SomaLogic meanwhile will receive 1.11 shares of Standard BioTools stock for each share they own and will post ...Somalogic Inc stock performance at a glance. Check Somalogic Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.SAN DIEGO, Jan. 5, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Proteomics Assay onto Illumina's current and future high throughput next-generation sequencing (NGS) platforms. This partnership accelerates the rapidly …

If SomaLogic Opco fails to make the Final Payment as and when due, interest shall thereafter accrue at a rate of 12% per annum until it is paid. Under the terms of the Leases, SomaLogic Opco was required to deliver a letter of credit in the amount of approximately $2,000,000 for each of Lease 1 and Lease 2 to secure the obligations …

SAN DIEGO, Jan. 5, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Proteomics Assay onto Illumina's current and future high throughput next-generation sequencing (NGS) platforms. This partnership accelerates the rapidly …

SomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.BOULDER, Colo., March 13, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, recently completed the 7,000-plex assay on and delivered data for 4,000 plasma samples from the China Kadoorie Biobank (CKB), one of the world’s largest prospective studies.Aug 15, 2023 · Shares of SomaLogic (SLGC-0.35%) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock ... BOULDER, Colo. and SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire ...Oct 4, 2023 · Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ... According to the issued ratings of 5 analysts in the last year, the consensus rating for SomaLogic stock is Hold based on the current 3 hold ratings and 2 buy ratings for SLGC. The average twelve-month price prediction for SomaLogic is $4.26 with a high price target of $7.00 and a low price target of $2.30. Learn more on SLGC's analyst rating ...

Shares of SomaLogic (SLGC-0.35%) ... The healthcare stock is down more than 9% this year. The move was considerable considering the stock was trading at $1.99 a share on Monday, just a penny above ...Founders David Brunel, Larry Gold. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name SomaLogic, Inc. Stock Symbol FRA:76X0. Company Type For Profit. Contact Email [email protected]. Phone Number 303-625-9000. SomaLogic operates as a protein biomarker discovery and clinical diagnostics company.Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …BOULDER — SomaLogic Inc. (Nasdaq: SLGC) and California-based Standard BioTools Inc. (Nasdaq: LAB) have agreed to an all-stock merger deal that is expected to result in a combined company valued at more than $1 billion. Existing executives with both companies will lead the combined organization, which will carry the Standard BioTools name.Mar 28, 2023 · SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized ... According to the issued ratings of 5 analysts in the last year, the consensus rating for SomaLogic stock is Hold based on the current 3 hold ratings and 2 buy ratings for SLGC. The average twelve-month price prediction for SomaLogic is $4.26 with a high price target of $7.00 and a low price target of $2.30. Learn more on SLGC's analyst rating ...Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...

SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized ...

SomaLogic (NASDAQ:SLGCW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership, community ranking and risk.Headline. SomaLogic Inc Class A. morningstar.com - November 22 at 6:40 PM. With 54% ownership of the shares, SomaLogic, Inc. (NASDAQ:SLGC) is heavily dominated by institutional owners. finance.yahoo.com - November 22 at 1:39 PM. SomaLogic, Inc. (NASDAQ:SLGC) Q3 2023 Earnings Call Transcript. …SomaLogic will host a conference call at 4:30 p.m. ET on Thursday, May 12, 2022, to discuss its first quarter 2022 financial results. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at March 31, ...SomaLogic to deliver 7,000-plex SomaScan® Platform to researchers in attractive Chinese proteomics market. SHANGHAI and BOULDER, Colo., May 10, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today that Biostar Technology Limited will be the company’s first authorized site in China …The ownership percentages with respect to the post-combination company following the Business Combination and PIPE Investment are based on aggregate Merger Consideration of 125,000,000 shares of CMLS II Class A Common Stock (assuming no cash elections will be made by SomaLogic stockholders) and assume 116,013,417 shares will be issued at ...SomaLogic Reports Second Quarter 2022 Financial Results. August 15, 2022 at 4:05 PM EDT. PDF Version. Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million. Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service business, macroeconomic and commercial factors.--SomaLogic, Inc., a leader in proteomics technology, today reported financial results for the quarter ended March 31, 2023. ... Common stock, $0.0001 par value; ...SomaLogic, Inc. Warrant (SLGCW) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

With Somalogic stock trading at $2.83 per share, the total value of Somalogic stock (market capitalization) is $532.24M. Somalogic stock was originally listed at a price of …

SomaLogic, Inc. Warrant (SLGCW) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Insider trades for Somalogic Inc (SLGC): buy, sell, award and other transactions for SLGC insiders.0001104659-23-106609.txt : 20231004 0001104659-23-106609.hdr.sgml : 20231004 20231004081127 ACCESSION NUMBER: 0001104659-23-106609 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT CRenowned investor Cathie Wood’s firm ARK Invest owns 11.02 million SLGC shares for a total value of $31.95 million, according to its latest 13F filing. The imputed share price was $2.90. SLGC has a 0.2% weight in ARK Invest and a 1.12% weight in ARK Genomic Revolution ETF (ARKG). ARK owns 4.97% of the company.Oct 4, 2023 · Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year Outlook Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …See the latest SomaLogic Inc Class A stock price (SLGC:XNAS), related news, valuation, dividends and more to help you make your investing decisions.(c) such stockholder’s earn-out pro rata share of any Earn-Out Shares (as defined below) to which such stockholder is entitled pursuant to the terms of the Merger Agreement.. The exchange ratio is currently expected to be 0.8426 shares of CMLS II Class A common stock per share of SomaLogic’s Class B common stock, after giving effect …Operator: Good afternoon, and welcome to SomaLogic's Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. - Part 2The average Somalogic stock price prediction forecasts a potential downside of 2.04% from the current SLGC share price of $2.45. What is SLGC's forecast return on assets (ROA) for 2023-2025? (NASDAQ: SLGC) forecast ROA is -9.99%, which is lower than the forecast US Health Information Services industry average of 8.41%.

BOULDER, Colo. and SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire ...Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...The current consensus among the four polled investment analysts is to buy stock in Somalogic Inc. This rating has remained steady since January, indicating a consistent positive outlook for the company’s performance. Somalogic Inc reported earnings per share of -$0.13 for the current quarter, suggesting a loss during this period.Oct 11, 2023 · "Based on stock prices, people don't seem to like this deal," said Kyle Mikson, an analyst with Canaccord Genuity who covers SomaLogic. "People knew Standard BioTools was going to buy something and SomaLogic makes a kind of sense, but I'm sure SomaLogic investors wanted a better premium and Standard BioTools investors wanted a more proven asset ... Instagram:https://instagram. tradestation vs interactive brokersnasdaq fubobest mid cap value stocksannheuser busch stock SomaLogic is a community of people with diverse expertise but a singular purpose — to foster the discovery of new, effective and safer treatments for patients while empowering more accurate diagnosis, prevention and treatment of disease through the next generation of proteomics. Our team of world-class scientists, directors and administrators ...EXEL. Exelixis, Inc. 21.50. +0.28. +1.32%. In this piece, we will take a look at the 12 best biotechnology stocks to buy under $20. For more stocks, head on over to 5 Best Biotech Stocks To Buy ... stock price predictionverizon dividends history Oct 4, 2023 · BOULDER — SomaLogic Inc. (Nasdaq: SLGC) and California-based Standard BioTools Inc. (Nasdaq: LAB) have agreed to an all-stock merger deal that is expected to result in a combined company valued at more than $1 billion. Existing executives with both companies will lead the combined organization, which will carry the Standard BioTools name. clne stock forecast The custom stock SOMAmer solutions for 10%, ... SomaLogic has filed patent applications on aspects of this work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Funding: This work was funded by SomaLogic. SomaLogic had no role in the original prospective CKD study.Research SomaLogic's (Nasdaq:SLGC) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Research SomaLogic's (Nasdaq:SLGC) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard …